Depression and Anxiety Symptom
Conditions
Keywords
machine learning approach, CBT, PST, depression, anxiety
Brief summary
To breakthrough the bottleneck identified, we will conduct a cross-sectional study to develop a symptom clustering model for depression and anxiety. A wide range of statistical methods as well as machine learning approaches were explored, and a cohesive hierarchical clustering algorithm will be used. After developing the model, a symptom-matched intervention program based on problem solving therapy will be formulated. We are supposed to examine whether its use for personalizing symptom-matched psychological treatment can lead to improved patient outcomes, compared with usual care. This project is expected to provide a new and precise method for the emotion management, which will provide a standardized intervention pathway combining screening with treatment for the management of depression symptom and anxiety symptom. A preciser intervention matched to individual symptoms may provide important insight in improving patient outcome as well as a standardized mood management pathway targeting to the early detection and intervention for community residents.
Interventions
Problem-solving therapy-based holistic emotion management interventions matched to individual symptoms
Routine psychological care and guidance on mood management
Sponsors
Study design
Eligibility
Inclusion criteria
* Aged between 18 and 64 years. PHQ-9 ≥10 and/or GAD-7 ≥8 at baseline assessment defined as the threshold for caseness.
Exclusion criteria
* People will be excluded if they meet any of the following criteria: 1. They are receiving psychological therapy during an interview for any mental health issue; 2. currently acutely suicidal or have attempted suicide in the past 2 months, as indicated by PHQ-9 item 9; 3. cognitively impaired or diagnosed with bipolar disorder or psychosis or experiencing psychotic symptoms; d) dependent on alcohol or drugs; e) living with an unstable or acute medical illness that would interfere with trial participation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The Patient Health Questionnaire (PHQ-9) | Baseline, week 1, week 2, week 3, week 4, week 5, week 6, week 7, week 8, week 12, week 20, week 32 |
| GAD-7 | Baseline, week 1, week 2, week 3, week 4, week 5, week 6, week 7, week 8, week 12, week 20, week 32 |
Secondary
| Measure | Time frame |
|---|---|
| PSQI | Baseline, week 1, week 4, week 6, week 8, week 12, week 20, week 32 |
| WHODAS 2.0 | Baseline, week 1, week 4, week 6, week 8, week 12, week 20, week 32 |
| EQ-5D-5L | Baseline, week 1, week 4, week 6, week 8, week 12, week 20, week 32 |
Countries
China